Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00554385 · ClinicalTrials.gov registry record · Phase 2
A Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
A Phase 2 study, sponsored by Abbott.
- Terminated
- Registry status
- Phase 2
- Development phase
- 283
- Enrollment target
NCT00554385 is a Phase 2 study that was terminated before completion, run by Abbott. The registered enrollment target is 283 participants.
The verdict
NCT00554385, a Phase 2 study, was terminated before completion, sponsored by Abbott.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 283 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the long-term safety and tolerability of ABT-089 in children with ADHD.
Interventions
- DRUG ABT-089
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 283 participants |
| Start Date | 2007-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00554385
The ClinicalTrials.gov registry entry for NCT00554385 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 283 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ABT-089 is the first listed.
NCT00554385 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00554385 about?
NCT00554385 is a clinical study titled "A Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)". The objective of this study is to evaluate the long-term safety and tolerability of ABT-089 in children with ADHD.
What is the current status of trial NCT00554385?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 283 participants. The study started on 2007-11.
What interventions are being tested in trial NCT00554385?
The interventions under investigation include: ABT-089 (DRUG).
Who is sponsoring clinical trial NCT00554385?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.